Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Kato, G.
Right arrow Articles by Maeda, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kato, G.
Right arrow Articles by Maeda, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

J. Biochem, 1999, Vol. 126, No. 5 957-961
© 1999 Japanese Biochemical Society


research-article

Neuron-specific Cdk5 Kinase Is Responsible for Mitosis-Independent Phosphorylation of c-Src at Ser75 in Human Y79 Retinoblastoma Cells

Goro Kato1 and Shuichiro Maeda

Department of Biochemistry, Yamanashi Medical University Nakakoma, Yamanashi 409-3898

1To whom correspondence should be addressed. E-mail: gkato{at}res.yamBnashi-med.ac.jp

c-Src is phosphorylated at specific serine and threonine residues during mitosis in fibroblastic and epithelial cells. These sites are phosphorylated in vitro by the mitotic kinase Cdkl (p34cdc2). In contrast, c-Src in Y79 human retinoblastoma cells, which are of neuronal origin, is phosphorylated at one of the mitotic sites, Ser75, throughout the cell cycle. The identity of the serine kinase that nonmitotically phosphorylates c-Src on Ser75 remains unknown. We now are able to show for the first time that Cdk5 kinase, which has the same consensus sequence as the Cdkl and Cdk2 kinases, is required for the phospho-rylation in asynchronous Y79 cells. The Ser75 phosphorylation was inhibited in a dose-dependent manner by butyrolactone I, a specific inhibitor of Cdk5-type kinases. Three stable subclones that have almost no kinase activity were selected by transfection of an antisense Cdk5-specific activator p35 construct into Y79 cells. The loss of the kinase activity caused an approximately 85% inhibition of the Ser75 phosphorylation. These results present compelling evidence that Cdk5/p35 kinase is responsible for the novel phosphorylation of c-Src at Ser75 in neuronal cells, raising the intriguing possibility that c-Src acts as an effector of Cdk5/p35 kinase during neuronal development.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
C. J. Strock, J.-I. Park, E. K. Nakakura, G. S. Bova, J. T. Isaacs, D. W. Ball, and B. D. Nelkin
Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells.
Cancer Res., August 1, 2006; 66(15): 7509 - 7515.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. R. Ledee, C. Y. Gao, R. Seth, R. N. Fariss, B. K. Tripathi, and P. S. Zelenka
A Specific Interaction between Muskelin and the Cyclin-dependent Kinase 5 Activator p39 Promotes Peripheral Localization of Muskelin
J. Biol. Chem., June 3, 2005; 280(22): 21376 - 21383.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. Y. Gao, M. A. Stepp, R. Fariss, and P. Zelenka
Cdk5 regulates activation and localization of Src during corneal epithelial wound closure
J. Cell Sci., August 15, 2004; 117(18): 4089 - 4098.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
G. Kato and S. Maeda
Production of Mouse ES Cells Homozygous for Cdk5-Phosphorylated Site Mutation in c-src Alleles
J. Biochem., May 1, 2003; 133(5): 563 - 569.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
D. S. Smith, P. L. Greer, and L.-H. Tsai
Cdk5 on the Brain
Cell Growth Differ., June 1, 2001; 12(6): 277 - 283.
[Abstract] [Full Text] [PDF]


Home page
Neuro Oncol DukeHome page
A. Catania, S. Urban, E. Yan, C. Hao, G. Barron, and J. Allalunis-Turner
Expression and localization of cyclin-dependent kinase 5 in apoptotic human glioma cells
Neuro-oncol, April 1, 2001; 3(2): 89 - 98.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.